Latest Director Loans News

Mt Malcolm Mine NL has supplemented its October Rights Issue with a $750,000 Placement Offer, updating its capital structure and funding plans to accelerate exploration and repay director loans.

Mt Malcolm Mines has successfully closed an oversubscribed $2.3 million rights issue and secured an additional $750,000 placement, positioning the company to fast-track exploration and development at its Malcolm Gold Project.

White Energy Company Limited has announced a partially underwritten entitlement offer to raise approximately $3.5 million at a 10% discount, aimed at funding key mineral exploration projects across Australia.

Genmin Limited has launched a A$25.7 million equity raising to advance its Baniaka iron ore project in Gabon, aiming for a final investment decision by mid-2026. The raise includes strategic collaboration with PowerChina and offers attaching options to investors.

Genmin Limited has locked in A$25.7 million through a two-tranche placement, including significant director loan conversions, to advance its flagship Baniaka iron ore project towards production.

Genmin Limited has made significant progress on its Baniaka iron ore project in Gabon, with PowerChina submitting competitive engineering and construction proposals and the company securing A$15 million in director-related loans during the quarter.

Pathkey.AI reports strong validation of its TrialKey AI platform’s predictive accuracy and announces key leadership changes as it advances toward commercial scale.

Genmin Limited’s non-executive directors have increased their loan funding by A$0.4 million and taken over a A$3 million loan from its largest shareholder, providing immediate working capital for the Baniaka iron ore project in Gabon.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Cullen Resources has secured key tenements and begun drilling at its Yardilla Gold Project while completing a A$1.5 million sale of its Wyloo Iron Ore Royalty, bolstering its exploration funding.

Zelira Therapeutics has made significant progress in its HOPE 1 clinical trial program, completing a key FDA submission and securing a $650,000 non-dilutive R&D loan facility to support ongoing development and working capital needs.

Mt Malcolm Mines NL has announced a pro-rata renounceable entitlement issue to raise up to $2.33 million, partially underwritten by Mahe Capital Pty Ltd. The capital raise aims to fund exploration drilling, repay director loans, and support working capital.